(R)-7'-((R)-Hydroxy(phenyl)methyl)-2,2',3,3'-tetrahydro-1,1'-spirobi[inden]-7-ol

Catalog No. :
ACEUSN594
CAS No. :
1451057-23-0
Molecular Formula :
C24H22O2
Molecular Weight :
342.44

IUPAC Name:(R)-7'-((R)-hydroxy(phenyl)methyl)-2,2',3,3'-tetrahydro-1,1'-spirobi[inden]-7-ol

(R)-7'-((R)-Hydroxy(phenyl)methyl)-2,2',3,3'-tetrahydro-1,1'-spirobi[inden]-7-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$394.00Login to see priceInquiryInquiry
1g98%$986.00Login to see priceInquiryInquiry
5g98%$2959.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-7'-((R)-Hydroxy(phenyl)methyl)-2,2',3,3'-tetrahydro-1,1'-spirobi[inden]-7-ol
IUPAC Name(R)-7'-((R)-hydroxy(phenyl)methyl)-2,2',3,3'-tetrahydro-1,1'-spirobi[inden]-7-ol
MDL No.MFCD30833853
Molecular FormulaC24H22O2
Molecular Weight342.44
SMILESO[C@H](C1=CC=CC=C1)C2=CC=CC3=C2[C@]4(CCC5=C4C(O)=CC=C5)CC3
InChI KeyFYJMCPGHDORIAI-DNQXCXABSA-N
Synonym(R)-7’-[(R)-Hydroxy(phenyl)methyl]-2,2’,3,3’-tetrahydro-1,1’-spirobi[inden]-7-ol;Ar-BINMOL-4;1,1'-Spirobi[1H-indene]-7-methanol, 2,2',3,3'-tetrahydro-7'-hydroxy-α-phenyl-, (αR,1R)-;(R)-7'-((S)-Hydroxy(phenyl)methyl)-2,2',3,3'-tetrahydro-1,1'-spirobi[inden]-7-ol;(αR,1R)-2,2',3,3'-Tetrahydro-7'-hydroxy-α-phenyl-1,1'-spirobi[1H-indene]-7-methanol
CAS No.1451057-23-0

Synthetic Route by SureRoute

1. ACEUSN594 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEUSN594 route product structure diagram
    ACEUSN5941451057-23-0
Inquiry

2. ACEUSN594 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEUSN594 route product structure diagram
    ACEUSN5941451057-23-0
Inquiry

Comments (0)